Vir Biotechnology, Inc. (VIR)
13.46
-0.18
(-1.36%)
USD |
NASDAQ |
Nov 10, 09:52
Vir Biotechnology Cash and Short Term Investments (Quarterly) : 460.29M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 460.29M |
| June 30, 2026 | 534.66M |
| March 31, 2026 | 478.22M |
| December 31, 2025 | 468.94M |
| September 30, 2025 | 508.73M |
| June 30, 2025 | 694.24M |
| March 31, 2025 | 889.81M |
| December 31, 2024 | 994.73M |
| September 30, 2024 | 1.004B |
| June 30, 2024 | 1.165B |
| March 31, 2024 | 1.163B |
| December 31, 2023 | 1.536B |
| September 30, 2023 | 1.710B |
| June 30, 2023 | 1.861B |
| March 31, 2023 | 2.261B |
| December 31, 2022 | 2.415B |
| Date | Value |
|---|---|
| September 30, 2022 | 2.359B |
| June 30, 2022 | 2.209B |
| March 31, 2022 | 1.274B |
| December 31, 2021 | 716.74M |
| September 30, 2021 | 945.56M |
| June 30, 2021 | 833.06M |
| March 31, 2021 | 741.63M |
| December 31, 2020 | 744.85M |
| September 30, 2020 | 835.96M |
| June 30, 2020 | 563.40M |
| March 31, 2020 | 364.71M |
| December 31, 2019 | 389.62M |
| September 30, 2019 | 329.03M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 109.20M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Moderna, Inc. | 5.171B |
| Vaxcyte, Inc. | 1.292B |
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Sangamo Therapeutics, Inc. | 27.59M |